Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.78
+0.0800 (+1.70%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.28 $5.69 Thursday, 9th May 2024 MBRX stock ended at $4.78. This is 1.70% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.54% from a day low at $4.61 to a day high of $5.05.
90 days $0.400 $6.23
52 weeks $0.338 $6.23

Historical Moleculin Biotech Inc prices

Date Open High Low Close Volume
Feb 28, 2024 $0.618 $0.618 $0.580 $0.610 95 579
Feb 27, 2024 $0.598 $0.642 $0.570 $0.616 186 232
Feb 26, 2024 $0.540 $0.589 $0.538 $0.589 113 853
Feb 23, 2024 $0.512 $0.540 $0.491 $0.540 143 172
Feb 22, 2024 $0.491 $0.515 $0.490 $0.515 53 627
Feb 21, 2024 $0.500 $0.510 $0.478 $0.501 72 462
Feb 20, 2024 $0.490 $0.516 $0.480 $0.500 40 413
Feb 16, 2024 $0.505 $0.520 $0.481 $0.498 107 481
Feb 15, 2024 $0.490 $0.530 $0.490 $0.500 35 689
Feb 14, 2024 $0.520 $0.520 $0.490 $0.510 63 245
Feb 13, 2024 $0.535 $0.535 $0.485 $0.510 60 586
Feb 12, 2024 $0.517 $0.561 $0.517 $0.517 76 622
Feb 09, 2024 $0.486 $0.517 $0.481 $0.517 42 224
Feb 08, 2024 $0.504 $0.518 $0.480 $0.493 134 969
Feb 07, 2024 $0.510 $0.520 $0.475 $0.520 117 162
Feb 06, 2024 $0.554 $0.560 $0.483 $0.512 138 040
Feb 05, 2024 $0.510 $0.520 $0.492 $0.519 57 977
Feb 02, 2024 $0.504 $0.514 $0.500 $0.507 61 259
Feb 01, 2024 $0.505 $0.520 $0.489 $0.517 112 722
Jan 31, 2024 $0.498 $0.505 $0.480 $0.504 81 816
Jan 30, 2024 $0.509 $0.520 $0.460 $0.504 72 793
Jan 29, 2024 $0.530 $0.530 $0.480 $0.490 88 596
Jan 26, 2024 $0.490 $0.516 $0.480 $0.486 38 724
Jan 25, 2024 $0.510 $0.514 $0.470 $0.488 180 093
Jan 24, 2024 $0.490 $0.536 $0.490 $0.507 523 510
Click to get the best stock tips daily for free!

About Moleculin Biotech Inc

Moleculin Biotech Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial fo... MBRX Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT